DeepMed Research

UNIVERSITY OF ILLINOIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1859-01-01

Employees: 10K

Market Cap: -

Website: http://www.illinois.edu

Clinical Trials

Hop Botanical Dietary Supplements - Metabolism and Safety in Women

Not Applicable

Completed

Conditions: Food-Drug Interactions

Interventions: Dietary Supplement: Humulus lupulus

First Posted Date: 2016-07-28

Last Posted Date: 2020-08-28

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 22

Registration Number: NCT02848430

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Proteomics and Stem Cell Therapy as a New Vascularization Strategy

Not Applicable

Completed

Conditions: Critical Limb Ischemia

Interventions: Device: Pneumatic calf compression
Drug: Filgrastim

First Posted Date: 2016-06-16

Last Posted Date: 2021-11-15

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 9

Registration Number: NCT02802852

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Patient-Centered Anticoagulation Self-Monitoring in Minority Patients

Not Applicable

Completed

Conditions: Blood Coagulation Disorders
Cardiovascular Disease
Thromboembolism
Vascular Disease

Interventions: Other: Patient Self-Monitoring vs Anticoagulation Clinic

First Posted Date: 2016-05-18

Last Posted Date: 2020-08-17

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 86

Registration Number: NCT02776566

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

HET Bipolar System: Validation of Outpatient Hemorrhoid Treatment

Not Applicable

Completed

Conditions: Hemorrhoids

Interventions: Procedure: HET Application

First Posted Date: 2016-05-16

Last Posted Date: 2021-06-03

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 35

Registration Number: NCT02773420

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Targeting Anhedonia in Cocaine Use Disorder

Phase 2

Completed

Conditions: Cocaine-Related Disorders
Anhedonia

Interventions: Drug: d-amphetamine
Behavioral: Contingency management
Drug: Placebo (for d-amphetamine)

First Posted Date: 2016-05-16

Last Posted Date: 2024-08-09

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 57

Registration Number: NCT02773212

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

A Community-based Implementation Model for HIV Prevention and Testing in Malawi

Not Applicable

Completed

Conditions: HIV CDC Category A1

Interventions: Behavioral: Mzake ndi Mzake T1
Behavioral: Mzake ndi Mzake T2
Behavioral: Mzake ndi Mzake T3

First Posted Date: 2016-05-06

Last Posted Date: 2021-11-15

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 1353

Registration Number: NCT02765659

Locations: 🇲🇼
Phalombe district communitie, Phalombe, Malawi

Pharmacokinetics of Telavancin in Normal and Obese Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Telavancin

First Posted Date: 2016-04-28

Last Posted Date: 2016-11-02

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 32

Registration Number: NCT02753855

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Impact of No-carrageenan Diet on Glucose Tolerance in Prediabetes

Not Applicable

Completed

Conditions: Prediabetes

Interventions: Other: No-carrageenan diet
Other: Regular Diet

First Posted Date: 2016-03-25

Last Posted Date: 2019-09-30

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 48

Registration Number: NCT02720393

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Acupuncture for Vulvodynia: A Pre-pilot Study

Not Applicable

Completed

Conditions: Dyspareunia
Pain
Vulvodynia
Vulvar Vestibulitis

Interventions: Other: Active Acupuncture
Other: Placebo Acupuncture

First Posted Date: 2016-03-09

Last Posted Date: 2024-02-21

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 6

Registration Number: NCT02704234

Locations: 🇺🇸
A Center for Oriental Medicine, Wilmette, Illinois, United States

rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease

Phase 1

Terminated

Conditions: Dry Eye
Ocular Graft vs Host Disease

Interventions: Drug: rhDNase I
Drug: Vehicle

First Posted Date: 2016-03-08

Last Posted Date: 2021-09-05

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 58

Registration Number: NCT02702518

Locations: 🇺🇸
Translational Clinic of Corneal Neurobiology laboratory, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸
University of Illinois Eye and Ear Infirmary, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy